Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01741727
Title A Study of ABT-414 in Subjects With Solid Tumors
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors AbbVie (prior sponsor, Abbott)
Indications

Advanced Solid Tumor

lung squamous cell carcinoma

Therapies

Depatuxizumab mafodotin

Age Groups: adult
Covered Countries USA | CAN


No variant requirements are available.